SangraMate

SangraMate Medical Warnings

Effective date: 22 October 2025
By using SangraMate, you accept these medical warnings in addition to our Terms of Use and Privacy Policy.
Indications for Use
SangraMate is a data-logging and shared-monitoring application intended to aid individuals managing blood glucose, insulin, meals, activity, and related events, and to support communication among invited carers/clinicians (your “Care Circle”).
It is designed for use in conjunction with primary diabetes monitoring devices (e.g., continuous glucose monitoring systems [CGMs], insulin pumps) and is not intended to replace them.
Important Warnings
  • SangraMate is not a medical device, not intended for diagnosis, treatment or monitoring of any disease or medical condition.
  • You must continue to use the primary, manufacturer-approved display of your CGM/pump or glucometer, and follow your healthcare professional’s instructions.
  • Do not make any therapy decisions based solely on data displayed by SangraMate.
  • SangraMate is not intended for controlling insulin pumps or drug delivery devices.
  • SangraMate should not be used by anyone unable to use mobile devices or computers proficiently.
  • You use SangraMate at your own risk. The app is provided “as is”.
Acknowledgement of Limitations
You acknowledge that:
  • Data may be delayed, incomplete, or inaccurate compared to the original CGM/pump system.
  • Graphs, trend lines, and estimates may be subject to error.
  • SangraMate cannot guarantee real-time alerts for dangerous glucose levels.
Usage with Care Circle
If you invite carers or clinicians:
  • They may view some of your logged data, but they are not substitutes for your primary care team.
  • You must still maintain control over your treatment decisions.
Emergency Situations
In the event of severe hypoglycaemia, hyperglycaemia, diabetic ketoacidosis (DKA), or any other urgent medical event — do not rely on SangraMate.
Call 000 (Australia) or go to your nearest emergency department immediately.